Compare Invesco S&P 500 Low Volatility ETF (SPLV) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco S&P 500 Low Volatility ETF vs Tempus AI — how do they compare? Invesco S&P 500 Low Volatility ETF trades at $72.16 (market cap $6.94B), while Tempus AI trades at $71.01 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, Invesco S&P 500 Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 Low Volatility ETF for 123 Days and Tempus AI for 23 Days on average.
| SPLV | TEM | |
|---|---|---|
Market Cap | $6.94B | $12.58B |
Volume | 1,663,703 | 7,444,569 |
52-Week High | $77.97 | $99.28 |
52-Week Low | $70.30 | $41.55 |
Typical Hold Time | 123 Days | 23 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPLV, the Invesco S&P 500 Low Volatility ETF, trades at $72.17 with a 1.33% daily gain. The ETF faces technical headwinds with a bearish moving average signal while oscillators remain neutral. Recent news highlights SPLV's underperformance versus the S&P 500, returning 5% versus 17%, due to sector overweights in Utilities, Real Estate, and Financials. The ETF maintains a 19.5x P/E ratio with upcoming dividend payments scheduled.
SPLV offers defensive exposure during market volatility but faces growth-adjusted valuation concerns. Key risks include concentrated sector exposure and lagging broad market performance. The neutral technical stance and mixed sentiment suggest cautious positioning for investors seeking low-volatility equity exposure amid geopolitical and economic uncertainty.
Tempus AI (TEM) trades at $71.46, up 1.66% with a bullish technical signal despite negative profitability metrics. The stock shows strong analyst support with 9 buy ratings and a $72.60 consensus target. Recent FDA clearance for ECG-MR AI product and 13 ESMO Congress presentations highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist at -$254M.
Outlook remains cautiously optimistic given strong institutional backing and AI healthcare growth potential, but profitability challenges and insider selling present near-term risks. The stock's valuation appears stretched with P/S of 8.61 and P/B of 28.27, requiring sustained revenue acceleration to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
